NM_001768.7:c.298C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001768.7(CD8A):​c.298C>T​(p.Leu100Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00225 in 1,614,138 control chromosomes in the GnomAD database, including 76 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 38 hom., cov: 33)
Exomes 𝑓: 0.0013 ( 38 hom. )

Consequence

CD8A
NM_001768.7 missense

Scores

2
9
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.73

Publications

5 publications found
Variant links:
Genes affected
CD8A (HGNC:1706): (CD8 subunit alpha) The CD8 antigen is a cell surface glycoprotein found on most cytotoxic T lymphocytes that mediates efficient cell-cell interactions within the immune system. The CD8 antigen acts as a coreceptor with the T-cell receptor on the T lymphocyte to recognize antigens displayed by an antigen presenting cell in the context of class I MHC molecules. The coreceptor functions as either a homodimer composed of two alpha chains or as a heterodimer composed of one alpha and one beta chain. Both alpha and beta chains share significant homology to immunoglobulin variable light chains. This gene encodes the CD8 alpha chain. Multiple transcript variants encoding different isoforms have been found for this gene. The major protein isoforms of this gene differ by the presence or absence of a transmembrane domain and thus differ in being a membrane-anchored or secreted protein. [provided by RefSeq, May 2020]
CD8A Gene-Disease associations (from GenCC):
  • susceptibility to respiratory infections associated with CD8alpha chain mutation
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009144366).
BP6
Variant 2-86790433-G-A is Benign according to our data. Variant chr2-86790433-G-A is described in ClinVar as Benign. ClinVar VariationId is 464446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0114 (1736/152326) while in subpopulation AFR AF = 0.0386 (1606/41576). AF 95% confidence interval is 0.0371. There are 38 homozygotes in GnomAd4. There are 802 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 38 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD8ANM_001768.7 linkc.298C>T p.Leu100Phe missense_variant Exon 2 of 6 ENST00000283635.8 NP_001759.3 P01732-1Q6ZVS2Q8TAW8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD8AENST00000283635.8 linkc.298C>T p.Leu100Phe missense_variant Exon 2 of 6 1 NM_001768.7 ENSP00000283635.3 P01732-1

Frequencies

GnomAD3 genomes
AF:
0.0114
AC:
1734
AN:
152208
Hom.:
38
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0387
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00576
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000382
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00301
AC:
756
AN:
251054
AF XY:
0.00222
show subpopulations
Gnomad AFR exome
AF:
0.0422
Gnomad AMR exome
AF:
0.00133
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00129
AC:
1888
AN:
1461812
Hom.:
38
Cov.:
33
AF XY:
0.00110
AC XY:
802
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.0454
AC:
1519
AN:
33476
American (AMR)
AF:
0.00161
AC:
72
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86258
European-Finnish (FIN)
AF:
0.000169
AC:
9
AN:
53370
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.000132
AC:
147
AN:
1111984
Other (OTH)
AF:
0.00219
AC:
132
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
110
221
331
442
552
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0114
AC:
1736
AN:
152326
Hom.:
38
Cov.:
33
AF XY:
0.0108
AC XY:
802
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0386
AC:
1606
AN:
41576
American (AMR)
AF:
0.00575
AC:
88
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000382
AC:
26
AN:
68036
Other (OTH)
AF:
0.00711
AC:
15
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
87
173
260
346
433
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00396
Hom.:
43
Bravo
AF:
0.0133
ESP6500AA
AF:
0.0413
AC:
182
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00351
AC:
426
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Susceptibility to respiratory infections associated with CD8alpha chain mutation Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.51
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.11
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.79
.;D;D;T
Eigen
Uncertain
0.52
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Benign
0.72
D
LIST_S2
Benign
0.61
T;.;T;T
MetaRNN
Benign
0.0091
T;T;T;T
MetaSVM
Uncertain
-0.10
T
MutationAssessor
Uncertain
2.7
M;M;M;.
PhyloP100
1.7
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-4.0
D;D;D;D
REVEL
Uncertain
0.58
Sift
Pathogenic
0.0
D;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D
Polyphen
1.0
D;D;D;.
Vest4
0.46
MVP
0.99
MPC
1.4
ClinPred
0.027
T
GERP RS
4.7
PromoterAI
-0.0065
Neutral
Varity_R
0.78
gMVP
0.67
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79392961; hg19: chr2-87017556; API